---
title: "TRIGIANT is expected to win a bid for China Mobile's centralized procurement project worth nearly 1.8 billion RMB"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266076059.md"
description: "TRIGIANT announced that its wholly-owned subsidiary, TRIGIANT Technology, is expected to win the bid for China Mobile's centralized procurement project for telecommunications power cable products from 2025 to 2026, with a bid price of nearly 1.8 billion RMB, ranking third with a share of 19.44%"
datetime: "2025-11-16T11:16:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266076059.md)
  - [en](https://longbridge.com/en/news/266076059.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266076059.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266076059.md) | [繁體中文](https://longbridge.com/zh-HK/news/266076059.md)


# TRIGIANT is expected to win a bid for China Mobile's centralized procurement project worth nearly 1.8 billion RMB

TRIGIANT (01300.HK) announced that its wholly-owned subsidiary, TRIGIANT Technology, is expected to win the bid for China Mobile's centralized procurement project for telecommunications power cable products from 2025 to 2026, with a bid price of nearly 1.8 billion RMB, ranking third with a share of 19.44%

### 相关股票

- [TRIGIANT (01300.HK)](https://longbridge.com/zh-CN/quote/01300.HK.md)

## 相关资讯与研究

- [China Mobile flirts with record dividend yield](https://longbridge.com/zh-CN/news/280987132.md)
- [Würth expands e-procurement integration to streamline B2B purchasing](https://longbridge.com/zh-CN/news/281064087.md)
- [China Mobile Limited Reports Earnings Results for the Full Year Ended December 31, 2025](https://longbridge.com/zh-CN/news/280669872.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md)
- [CICC Sticks to Its Buy Rating for C&D International Investment Group Ltd. (1908)](https://longbridge.com/zh-CN/news/280899096.md)